Bank Of New York Mellon Corp Citius Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.78 - $1.42 $40,976 - $74,598	52,534 New	52,534 $61.5 Million
Q4 2022 Feb 14, 2023	BUY	$0.79 - $1.23 $41,501 - $64,616	52,534 New	52,534 $41,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.87 $287,566 - $611,078	-326,780 Reduced 86.15%	52,534 $48,000
Q1 2022 May 11, 2022	BUY	$1.38 - $1.89 $22,373 - $30,642	16,213 Added 4.47%	379,314 $679,000
Q4 2021 Feb 11, 2022	BUY	$1.51 - $2.2 $9,331 - $13,596	6,180 Added 1.73%	363,101 $559,000

Q3 2021 Nov 12, 2021	BUY	$1.74 - $2.6 $42,826 - $63,993	24,613 Added 7.41%	356,921 $724,000
Q2 2021 Aug 11, 2021	BUY	$1.51 - $4.23 $422,458 - $1.18 Million	279,774 Added 532.56%	332,308 $1.16 Million
Q1 2021 May 13, 2021	BUY	$1.04 - $2.34 $54,635 - $122,929	52,534 New	52,534 $93,000

26.7M

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $140M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.